We are live on
!
Find out more
KCM
Kingdon Capital Management Portfolio holdings
AUM
$976M
1-Year Est. Return
66.76%
This Fund
S&P 500
This Quarter
Est. Return
+26.25%
1 Year Est. Return
+66.76%
3 Year Est. Return
+217.15%
5 Year Est. Return
+352.97%
10 Year Est. Return
+2,412.55%
AUM
$925M
AUM Growth
+$33.9M
(+3.8%)
Cap. Flow
-$174M
Cap. Flow
% of AUM
-18.85%
Top 10 Holdings %
Top 10 Hldgs %
56.49%
Holding
80
New
21
Increased
13
Reduced
13
Closed
24
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Baidu
BIDU
|
+$15.7M |
| 2 |
Flex
FLEX
|
+$12.1M |
| 3 |
Workday
WDAY
|
+$10.7M |
| 4 |
RADI
Radius Global Infrastructure, Inc. Class A Common Stock
RADI
|
+$9.76M |
| 5 |
Lithia Motors
LAD
|
+$7.62M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$28.4M |
| 2 |
XLRN
Acceleron Pharma
XLRN
|
+$26.9M |
| 3 |
Purple Innovation
PRPL
|
+$19.6M |
| 4 |
SPLK
Splunk Inc
SPLK
|
+$15.8M |
| 5 |
Nomad Foods
NOMD
|
+$15.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 32.08% |
| 2 | Healthcare | 25.01% |
| 3 | Consumer Discretionary | 12.8% |
| 4 | Communication Services | 9.57% |
| 5 | Industrials | 8.63% |
Similar funds
PHP
ACM
FM
PFGIA
PAMI
SI
ZI
RIA
Kingdon Capital Management's Q4 2020 Portfolio in Review
As of Q4 2020, Kingdon Capital Management held 80 positions worth $925M, up 3.8% from $891M the previous quarter. Its ten largest holdings account for 56% of the portfolio.
Kingdon Capital Management withdrew a net $174M in Q4 2020, closing 24 positions and reducing 13 holdings. Its most notable exit was Merck, an estimated $28.4M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 32% of assets, up from 22% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Kingdon Capital Management opened a new position in Baidu worth $22.9M.
- Kingdon Capital Management's largest Q4 2020 buy was Baidu: 105,815 shares worth $22.9M.
- Kingdon Capital Management added most to Lithia Motors in Q4 2020, an estimated $7.62M increase.
- Kingdon Capital Management's biggest Q4 2020 reduction was Acceleron Pharma, cutting an estimated $26.9M.
- Kingdon Capital Management fully exited Merck in Q4 2020, selling an estimated $28.4M.
- Kingdon Capital Management's ten largest holdings make up 56% of its $925M portfolio in Q4 2020.
- Kingdon Capital Management opened 21 new positions and closed 24 in Q4 2020.
- Kingdon Capital Management's portfolio value rose 3.8% quarter-over-quarter to $925M.
Based on Kingdon Capital Management's 13F filing for Q4 2020, filed 16 Feb 2021.